These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28273393

  • 1. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.
    Helfrich M, Dorschner P, Thomas K, Stosor V, Ison MG.
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273393
    [Abstract] [Full Text] [Related]

  • 2. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
    Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M.
    Lancet; 2000 Aug 19; 356(9230):645-9. PubMed ID: 10968438
    [Abstract] [Full Text] [Related]

  • 3. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD.
    Am J Kidney Dis; 2002 May 19; 39(5):1088-95. PubMed ID: 11979354
    [Abstract] [Full Text] [Related]

  • 4. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.
    Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM, Smith JA, Mandelbrot DA.
    Transpl Infect Dis; 2019 Jun 19; 21(3):e13080. PubMed ID: 30891915
    [Abstract] [Full Text] [Related]

  • 5. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP, Chen JM, Fridell JA.
    Clin Transplant; 2015 Dec 19; 29(12):1221-9. PubMed ID: 26458498
    [Abstract] [Full Text] [Related]

  • 6. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.
    Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, Shutt KA, Shapiro R, Thai N, Abu-Elmagd K, McCurry KR, Marcos A, Paterson DL.
    Clin Infect Dis; 2007 Jan 15; 44(2):204-12. PubMed ID: 17173218
    [Abstract] [Full Text] [Related]

  • 7. Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience.
    Florescu DF, Seaman JA, Kalil AC, Qiu F, Bremers D, Westphal SG.
    Transplant Proc; 2021 Apr 15; 53(3):1058-1063. PubMed ID: 32921434
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013 Apr 15; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.
    Gabardi S, Asipenko N, Fleming J, Lor K, McDevitt-Potter L, Mohammed A, Rogers C, Tichy EM, Weng R, Lee RA.
    Transplantation; 2015 Jul 15; 99(7):1499-505. PubMed ID: 25643140
    [Abstract] [Full Text] [Related]

  • 10. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM, Jang IA, Lee D, Kang EJ, Choi BS, Park CW, Choi YJ, Yang CW, Kim YS, Chung BH.
    Korean J Intern Med; 2015 Nov 15; 30(6):865-72. PubMed ID: 26552462
    [Abstract] [Full Text] [Related]

  • 11. Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients.
    Heldenbrand S, Li C, Cross RP, DePiero KA, Dick TB, Ferguson K, Kim M, Newkirk E, Park JM, Sudaria-Kerr J, Tichy EM, Ueda KR, Weng R, Wisniewski J, Gabardi S.
    Transpl Infect Dis; 2016 Dec 15; 18(6):904-912. PubMed ID: 27639246
    [Abstract] [Full Text] [Related]

  • 12. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN, Hamade A, El Mountahi F, Racapé J, Hougardy JM, Le Moine A, Vereerstraeten P.
    Transpl Infect Dis; 2016 Dec 15; 18(6):872-880. PubMed ID: 27615506
    [Abstract] [Full Text] [Related]

  • 13. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.
    Helfrich M, Ison MG.
    Transpl Infect Dis; 2015 Oct 15; 17(5):627-36. PubMed ID: 26228653
    [Abstract] [Full Text] [Related]

  • 14. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC, Bodson-Clermont P, St-Louis G, Pâquet MR, Girardin C, Fortin MC, Cardinal H, Hébert MJ, Lévesque R, Renoult E.
    Transpl Infect Dis; 2017 Jun 15; 19(3):. PubMed ID: 28207975
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 16. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F, Mohsin N, Kamble P.
    Exp Clin Transplant; 2015 Apr 27; 13 Suppl 1():156-8. PubMed ID: 25894146
    [Abstract] [Full Text] [Related]

  • 17. Incidence and risk factors of common viral infections among renal transplant recipients during the first year post-transplant in North-eastern Iran.
    Eidgahi ES, Lotfi Z, Tayefi M, Bahrami A, Shams SF, Shakeri S, Sheikhi M.
    Saudi J Kidney Dis Transpl; 2019 Apr 27; 30(3):597-605. PubMed ID: 31249223
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of varicella zoster virus infection morbidity and mortality in pancreas and kidney-pancreas transplant recipients.
    Netchiporouk E, Tchervenkov J, Paraskevas S, Sasseville D, Billick R.
    Transplant Proc; 2013 Mar 27; 45(2):701-4. PubMed ID: 23453544
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C viremia as a risk factor for opportunistic infections in kidney transplant recipients.
    Bodro M, Londoño MC, Esforzado N, Sanclemente G, Linares L, Solano MF, Cofan F, Marcos MA, Diekmann F, Moreno A.
    Clin Transplant; 2018 Oct 27; 32(10):e13382. PubMed ID: 30129986
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S, Haberal M.
    Transplant Proc; 2013 Oct 27; 45(10):3520-3. PubMed ID: 24314948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.